Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2012; 18(17): 2026-2034
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2026
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2026
Table 2 Histopathological evaluation of the patients before and after treatment n (%)
| Conventional group | AHM group | |||||
| Before | After | χ2/P | Before | After | χ2/P | |
| Grade | ||||||
| 0 | 0 (0) | 3 (15) | 4.390/ | 0 (0) | 3 (15) | 9.390/ |
| 1 | 3 (15) | 5 (25) | 0.223 | 3 (15) | 9 (45) | 0.024a |
| 2 | 9 (45) | 6 (30) | 10 (50) | 4 (20) | ||
| 3 | 8 (40) | 6 (30) | 7 (35) | 4 (20) | ||
| Stage | ||||||
| 0 | 0 (0) | 0 (0) | 0.000/ | 0 (0) | 2 (10) | 6.170/ |
| 1 | 3 (15) | 3 (15) | 1.000 | 3 (15) | 7 (35) | 0.103 |
| 2 | 9 (45) | 9 (45) | 10 (50) | 4 (20) | ||
| 3 | 8 (40) | 8 (40) | 7 (35) | 7 (35) | ||
- Citation: Hegazy SK, El-Bedewy M, Yagi A. Antifibrotic effect of aloe vera in viral infection-induced hepatic periportal fibrosis. World J Gastroenterol 2012; 18(17): 2026-2034
- URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2026.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2026